ciprofloxacin has been researched along with Cardiac Toxicity in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to investigate the impacts of Doxo alone and in combination with Cipro on the hepatic and cardiac CYP1A2, CYP2J3, and CYP3A1 mRNA levels." | 5.91 | Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function. ( Basci, AB; Eyileten, C; Karatas, OF; Postula, M; Shahzadi, A; Suzer, O; Tanoglu, EG; Yazici, Z, 2023) |
| "This study was designed to investigate the impacts of Doxo alone and in combination with Cipro on the hepatic and cardiac CYP1A2, CYP2J3, and CYP3A1 mRNA levels." | 1.91 | Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function. ( Basci, AB; Eyileten, C; Karatas, OF; Postula, M; Shahzadi, A; Suzer, O; Tanoglu, EG; Yazici, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shahzadi, A | 3 |
| Eyileten, C | 3 |
| Postula, M | 3 |
| Tanoglu, EG | 3 |
| Karatas, OF | 3 |
| Basci, AB | 3 |
| Suzer, O | 3 |
| Yazici, Z | 3 |
1 other study available for ciprofloxacin and Cardiac Toxicity
| Article | Year |
|---|---|
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats | 2023 |